Invent targeted small molecule drugs
that are either first-in-class or second-generation

Selectively develop our drugs
to maximize their overall value

Perform a partnering strategy
in which we retain profit rights for drugs
through partner select early-stage programs

ABOUT US

BiSiChem is a leading biotech company that focused on the discovery and
development of innovative therapeutic drugs on immuno-oncology,
targeted therapy and neuro-degenerative diseases.

Our goals are Good lives, Better innovation and Best therapy.

HISTORY
LEADERSHIP

Our main focus is
“BiSiChem is a precision medicine company
developing a specific targeted therapy to treat cancer.”

VISION OF SCIENCE

Breakthrough discovery of therapeutics for unmet medical needs,
biomarker-based innovative, first-in-class or best-in-class candidates development

pipeline
Research center

BiSiChem has a strength on preclinical candidate selection by target selection,
medicinal chemistry, biology and DMPK experties.

R&D Research Center. Pangyo

New Drug Research Center. Yongin

COLLABORATION

Lifex Biolabs Inc.

PLATBIO Inc.

Interpark Bio Convergence Corp.

Asan Medical Center

contact
address

3F, Pangyo-ro 255beon-gil 74,
Bundang-gu, Seongnam-si,
Gyeonggi-do, Republic of Korea

Contact

Tel +82-31-698-3772
Fax +82-70-7610-2776
E-mail [email protected]

Map

kakao map